Hinge Health (HNGE) has moved back to a key support level during the recent market sell-off, which puts a spotlight on how its sharply higher year-to-date performance fits with the latest guidance and fundamentals.
The short-term picture has cooled, with the share price down 2.15% over one day and 8.33% over the past week. Hinge Health still carries a 30 day share price return of 5.55% lower, against a 19.63% gain over 90 days and a 132.18% year to date share price return. The 1 year total shareholder return of 130.01% points to strong momentum that has only recently started to fade at the edges as investors reassess growth potential and risk after management lifted medium term revenue guidance and broadened its digital care offering.
Scan beyond Hinge Health's pullback and see how other medical and tech-enabled care stocks with similar momentum and fundamentals stack up in the 35 healthcare AI stocks.
After a 130% one year return and a quick step back to support, Hinge Health now asks a simple question: Does the current valuation still leave enough upside to justify the volatility risk?
Compared with Hinge Health's last close at $105.78, the most followed narrative fair value of $145.04 points to a sizeable valuation gap, which frames how some investors see the risk reward trade off today according to Ontological, an investor in the Simply Wall St Community who wrote the narrative.
Hinge Health has quickly distinguished itself as one of the most successful IPOs of 2025, combining rapid revenue growth, widening margins, and a scalable AI driven care model. The company’s focus on musculoskeletal (MSK) health, covering prevention, acute injury, chronic pain, and post surgical recovery, has resonated with employers and insurers, driving adoption across millions of contracted lives.
See why 4 investors see Hinge Health as 27% undervalued.
Result: Fair Value of $145.04 (UNDERVALUED)
Still, Hinge Health faces real pressure if elevated valuation multiples compress, or if regulatory and reimbursement scrutiny slows employer and insurer adoption.
Find out about the key risks to this Hinge Health narrative.
There is a catch. On simple earnings multiples, Hinge Health trades on a P/E of 51.7x, compared with 37.9x for peers and 25x for the wider US Healthcare sector. The fair ratio sits at 35.2x, and that gap points to real valuation risk if expectations cool.
For a closer look at what this richer multiple could mean for Hinge Health if sentiment or growth assumptions shift, See what the numbers say about this price — find out in our valuation breakdown.
Conflicted about whether the optimism in Hinge Health's story matches the numbers on screen today? Move quickly, pull up the full breakdown, and weigh the 4 key rewards.
If Hinge Health has sharpened your focus on opportunity and risk, do not stop here. Broaden your watchlist now and avoid missing other compelling setups.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com